BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10051963)

  • 1. Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae.
    Cuffini AM; Tullio V; Ianni Palarchio A; Bonino A; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1998; 24(4):173-84. PubMed ID: 10051963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibacterial activity of amoxycillin/clavulanic acid against Staphylococcus aureus ingested by human granulocytes.
    Cuffini AM; Tullio V; Allocco A; Paizis G; Carlone NA
    Microbios; 1996; 87(350):31-8. PubMed ID: 8972100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The postantibiotic effect of amoxicillin/clavulanic acid on Streptococcus pneumoniae strains of different serotypes and penicillin sensitivity].
    García Y; Gómez MJ; Ramos MC; Gómez-Lus ML; Prieto J
    Rev Esp Quimioter; 1998 Jun; 11(2):157-60. PubMed ID: 9795302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    Anon JB; Ferguson B; Twynholm M; Wynne B; Berkowitz E; Poole MD
    Ear Nose Throat J; 2006 Aug; 85(8):500, 502, 504 passim. PubMed ID: 16999056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin mediated the expression of polymorphonuclear granulocyte response against streptococcus pneumoniae strains with different patterns of susceptibility and resistance to penicillin and clarithromycin.
    Cuffini AM; Tullio V; Mandras N; Roana J; Scalas D; Banche G; Carlone NA
    Int J Tissue React; 2002; 24(1):37-44. PubMed ID: 12013153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity against Streptococcus pneumoniae.
    Martín M; Gómez-Lus ML; Aguilar L; Martínez P; Giménez MJ; Prieto J
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):512-6. PubMed ID: 9272386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
    Cuffini AM; Tullio V; Paizis G; Carlone NA
    J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carrier rate of Streptococcus pneumoniae and susceptibility thereof to antimicrobial drugs among children in China: a surveillance study in Beijing, Shanghai, and Guangzhou 2000-2002].
    Yao KH; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Shen XZ; Yang YH
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(28):1957-61. PubMed ID: 16313770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model].
    Gómez-Lus ML; García Y; Valero E; Amores R; Fuentes F
    Rev Esp Quimioter; 2000 Sep; 13(3):306-13. PubMed ID: 11086282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
    Etesse-Carsenti H; Garraffo R; Bernard E; de Salvador F; Pradier C; Durant J; Mondain V; Drugeon HB; Dellamonica P
    Pathol Biol (Paris); 1991 Dec; 39(10):972-7. PubMed ID: 1805138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibilities of amoxycillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniae.
    Pérez-Trallero E; Marimón JM; Ercibengoa M; Giménez MJ; Coronel P; Aguilar L
    Clin Microbiol Infect; 2007 Sep; 13(9):937-40. PubMed ID: 17617182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens.
    Odenholt I; Cars O; Löwdin E
    J Antimicrob Chemother; 2004 Dec; 54(6):1062-6. PubMed ID: 15563517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
    Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
    Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996.
    Butler DL; Gagnon RC; Miller LA; Poupard JA; Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 1999 Jun; 43(6):777-82. PubMed ID: 10404316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the bactericide activity of the combination amoxycillin/clavulanic acid and its possible effects in the resistance of beta-lactam drugs].
    Prieto J; Frías J; Alou L; Carcas A
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():12-5. PubMed ID: 9717154
    [No Abstract]   [Full Text] [Related]  

  • 20. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
    Li J; Zhang Y; Chen Y; Hao F; Chen Y
    Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.